Ashley Gallagher, MA

Tezspire gains FDA approval as the first biologic for chronic rhinosinusitis with nasal polyps, offering improved patient outcomes.

Pharmacists enhance patient care through automation, blood pressure monitoring, and community health services, improving accessibility and reducing burnout.

FDA approves oral semaglutide for reducing cardiovascular risks in high-risk type 2 diabetes patients, enhancing treatment options and outcomes.

A recent study reveals a heightened stroke risk in asthma patients recovering from severe COVID-19, emphasizing the need for proactive monitoring and management.

The FDA expands Yuflyma's approval to treat hidradenitis suppurativa and uveitis in pediatric patients, enhancing treatment options for chronic conditions.

Orforglipron demonstrates superior glycemic control in phase 3 trials, showing promise as a new treatment for type 2 diabetes.

The FDA approves the Insti HIV Self Test, enabling rapid, accurate results in just one minute, enhancing access to HIV testing nationwide.

A study shows young adults with 3 or more COVID-19 vaccine doses experience fewer symptoms, emphasizing vaccination's critical role in public health.

As misinformation persists, health experts and research point to pharmacists as key communicators in building trust and boosting immunization rates.

CVS Pharmacy acquires Rite Aid assets in the Pacific Northwest, enhancing pharmacy access while addressing the growing crisis of pharmacy closures nationwide.

The biosimilar is also approved for indications of Eylea, including neovascular age-related macular degeneration, macular edema following retinal vein occlusion, and diabetic retinopathy.

The FDA approves Uzedy, a long-acting risperidone injection, enhancing treatment options for adults with bipolar I disorder and addressing unmet needs.

Pharmacists navigate financial challenges and evolving roles, requiring communication and problem-solving skills amid technological advancements.

David Nau, BSPH, PhD, discusses evolving landscape of pharmacy, highlighting resilience, innovation, and new opportunities for future pharmacists in a changing health care world.

Pharmacists evolve by enhancing skills, embracing AI, and focusing on patient care, ensuring relevance in a changing health care landscape.

Further, they found weight loss prior to 75-g oral glucose tolerance test was a preventive factor for both impaired glucose tolerance and diabetes.

Amgen launches AmgenNow, which is a new direct-to-patient program that will start with evolucumab.

Don Roosan, PharmD, PhD, discusses the ethical implications of AI in pharmacy, focusing on patient safety, transparency, and the importance of human connection in care.

Don Roosan, PharmD, PhD, discusses the changing technology, challenging conventional boundaries of pharmaceutical practice through telepharmacy and artificial intelligence.

Prior to the government shutdown, the FDA approved a generic version of mifeprisone without a public announcement.

This is the first Bruton tyrosine kinase inhibitor FDA approved for chronic spontaneous urticaria.

This month, Drug Topics® explores a new avenue of pharmacy each week, including AI technology, student education, innovative community services, and the expansion of clinical care.

Since 2016, the rate of gabapentin prescribing slowed but is still increasing, especially for women and older adults.

This marks the first and only IL-23 approval for these indications in pediatric populations.

Pharmacists are on the front line for patients looking to self-manage their menstrual pain, making their role invaluable in women’s health.

The study results highlight the importance of pneumococcal vaccination for patients with chronic respiratory diseases, particularly chronic obstructive pulmonary disease.

Investigators examine the effects of combination therapy with metformin combined with sodium-glucose cotransporter-2 inhibitors, dipeptidyl peptidase-4 inhibitors, or thiazolidinediones.

Further, after the introduction of the pneumococcal conjugate vaccine 10, investigators note a decrease of infections caused by multidrug resistance infection.

As part of this announcement, the administration launches initiatives across the National Institutes of Health, the FDA, and the Center for Medicare & Medicaid Services.

The vote for state and local jurisdictions requiring a prescription for administration of COVID-19 vaccines failed after a tiebreaker vote from the committee chair.